---
schema_version: "secwatch.filing_event.v1"
accession: "0000937556-24-000062"
form_type: "8-K"
ticker: "MASI"
cik: "0000937556"
company_name: "MASIMO CORP"
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:54:32.002995+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Masimo Q2 revenue $496.3M, GAAP EPS $0.29, non-GAAP $0.86; raises FY2024 guidance

## Summary
- Healthcare revenue $343.9M, non-healthcare $152.4M; GAAP operating income $28.3M, non-GAAP $72.9M.
- GAAP net income $16.0M ($0.29/diluted share); non-GAAP net income $46.6M ($0.86/diluted share).
- Raises FY2024 guidance: consolidated revenue $2,085-$2,135M, healthcare $1,385-$1,405M.
- FY2024 non-GAAP EPS guidance raised to $3.80-$4.00; Q3 revenue guidance $495-$515M.
- CEO cites record-breaking contracting, margin expansion, and innovation for strong results.

## SEC filing metadata
- accession: 0000937556-24-000062
- form_type: 8-K
- ticker: MASI
- cik: 0000937556
- company_name: MASIMO CORP
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/937556/000093755624000062/0000937556-24-000062-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/937556/000093755624000062/masi-20240806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000937556-24-000062
- JSON: https://secwatch.observer/filing/0000937556-24-000062.json
- Plain text: https://secwatch.observer/filing/0000937556-24-000062.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.